Trastuzumab plus capecitabine and docetaxel as first-line therapy for HER2-positive metastatic breast cancer: phase II results. (Q42947558)
Jump to navigation
Jump to search
scientific article published on July 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Trastuzumab plus capecitabine and docetaxel as first-line therapy for HER2-positive metastatic breast cancer: phase II results. |
scientific article published on July 2010 |
Statements
Trastuzumab plus capecitabine and docetaxel as first-line therapy for HER2-positive metastatic breast cancer: phase II results (English)
Vasiliki Michalaki
Stylianos Fotiou
Spyridon Gennatas
Constantine Gennatas